Cantor Fitzgerald Has Weak Outlook for Amgen FY2025 Earnings
Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to ...
What is William Blair’s Forecast for Amgen FY2025 Earnings?
Investment analysts at William Blair reduced their FY2025 earnings per share estimates for Amgen in a report released on Wednesday, February 5th. William Blair analyst M. Phipps now anticipates that ...
emjreviews.com5h
Secukinumab Proves Effective in Real-World Psoriatic Arthritis Treatment
SECUKINUMAB (SECU) demonstrates sustained effectiveness and high drug survival rates in patients with moderate-to-severe ...